Dr. Robert Allen Burger from Fox Chase Cancer Center discusses the new study with the Gynecologic Cancer Group showing Avastin (bevacizumab) boosts progression-free survival in ovarian cancer.
Keywords: Dr. Robert Burger, Fox Chase Cancer Center, Selma Schimmel, Understanding Cancer, ASCO, clinical trials, ovarian cancer, cancer screening, Avastin, bevacizumab, Gynecologic Oncology Group
ไม่มีความคิดเห็น:
แสดงความคิดเห็น